BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 10080423)

  • 1. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.
    Schumacher B; Jung W; Lewalter T; Vahlhaus C; Wolpert C; Lüderitz B
    Am J Cardiol; 1999 Mar; 83(5):710-3. PubMed ID: 10080423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation.
    Nabar A; Rodriguez LM; Timmermans C; Smeets JL; Wellens HJ
    Am J Cardiol; 1999 Mar; 83(5):785-7, A10. PubMed ID: 10080440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation.
    Stabile G; De Simone A; Turco P; La Rocca V; Nocerino P; Astarita C; Maresca F; De Matteis C; Di Napoli T; Stabile E; Vitale DF
    J Am Coll Cardiol; 2001 May; 37(6):1639-44. PubMed ID: 11345378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
    Cosedis Nielsen J; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Hansen PS
    N Engl J Med; 2012 Oct; 367(17):1587-95. PubMed ID: 23094720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation.
    Anastasio N; Frankel DS; Deyell MW; Zado E; Gerstenfeld EP; Dixit S; Cooper J; Lin D; Marchlinski FE; Callans DJ
    J Interv Card Electrophysiol; 2012 Oct; 35(1):57-61. PubMed ID: 22552760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter.
    Reithmann C; Dorwarth U; Dugas M; Hahnefeld A; Ramamurthy S; Remp T; Steinbeck G; Hoffmann E
    Eur Heart J; 2003 Jul; 24(13):1264-72. PubMed ID: 12831821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.
    Prakash A; Saksena S; Krol RB; Filipecki A; Philip G
    J Interv Card Electrophysiol; 2002 Jun; 6(2):165-72. PubMed ID: 11992027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.
    Nabar A; Rodriguez LM; Timmermans C; van Mechelen R; Wellens HJ
    Heart; 2001 Apr; 85(4):424-9. PubMed ID: 11250970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation recurrence after drug-induced typical atrial flutter ablation.
    Bandini A; Golia P; Pantoli D; Galvani M; Rusticali F
    Ital Heart J; 2005 Jul; 6(7):584-90. PubMed ID: 16274021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction.
    Tai CT; Chiang CE; Lee SH; Chen YJ; Yu WC; Feng AN; Ding YA; Chang MS; Chen SA
    J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1180-7. PubMed ID: 10517649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different clinical courses and predictors of atrial fibrillation occurrence after transisthmic ablation in patients with preablation lone atrial flutter, coexistent atrial fibrillation, and drug induced atrial flutter.
    Bertaglia E; Bonso A; Zoppo F; Proclemer A; Verlato R; Corò L; Mantovan R; Themistoclakis S; Raviele A; Pascotto P;
    Pacing Clin Electrophysiol; 2004 Nov; 27(11):1507-12. PubMed ID: 15546305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group.
    Aliot E; Denjoy I
    Am J Cardiol; 1996 Jan; 77(3):66A-71A. PubMed ID: 8607394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
    Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
    JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
    G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
    Suttorp MJ; Kingma JH; Jessurun ER; Lie-A-Huen L; van Hemel NM; Lie KI
    J Am Coll Cardiol; 1990 Dec; 16(7):1722-7. PubMed ID: 2123909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catheter ablation of atrial flutter and atrial fibrillation].
    Kobza R; Hindricks G; Kottkamp H
    Ther Umsch; 2004 Apr; 61(4):234-8. PubMed ID: 15137517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of hybrid pharmacologic and ablation therapy in patients with pilsicainide-induced atrial flutter.
    Hirao K; Okishige K; Yamamoto N; Otomo K; Azegami K; Isobe M
    Clin Cardiol; 2005 Jul; 28(7):338-42. PubMed ID: 16075827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation.
    Huang DT; Monahan KM; Zimetbaum P; Papageorgiou P; Epstein LM; Josephson ME
    J Cardiovasc Electrophysiol; 1998 May; 9(5):462-9. PubMed ID: 9607453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion.
    Turco P; De Simone A; La Rocca V; El Jamal B; Nocerino P; Astarita C; De Matteis C; Messina V; Greco L; Rotunno R; Di Napoli T; Vitale DF; Stabile G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S124-7. PubMed ID: 15683478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.